Category: Therapeutics/pharmacology

W.86 - Mitigation of Anti-drug Antibodies Against a Peglylated Uricase in Patients with Hyperuricemia Results in Enhanced Control of Serum Uric Acid

Wednesday, Jun 14
6:15 PM – 7:45 PM

Earl Johnston

COO
Selecta Biosciences
Watertown, Massachusetts

Takashi KEI.. Kishimoto

Chief Scientific Officer
Selecta Biosciences
Watertown, Massachusetts

Alan Kivitz

Altoona Center for Clinical Research
Altoona, Pennsylvania

Earl Sands

Chief Medical Officer
Selecta Biosciences
Watertown, Massachusetts